Ratings
0
Nobody has rated this yet. Be the first!
Works
14
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.
Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients
DNA methylation in serum of breast cancer patients: an independent prognostic marker
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer
Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool
DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients
Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
